This is a synthetic peptide designed for use in combination with anti-MNAT1 antibody (Catalog #: ARP38150_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Purification
Purified
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Cyclin-dependent kinases (CDKs), which play an essential role in cell cycle control of eukaryotic cells, are phosphorylated and thus activated by the CDK-activating kinase (CAK). CAK is a multisubunit protein that includes CDK7, cyclin H, and MAT1. MAT1 (for 'menage a trois-1') is involved in the assembly of the CAK complex.Cyclin-dependent kinases (CDKs), which play an essential role in cell cycle control of eukaryotic cells, are phosphorylated and thus activated by the CDK-activating kinase (CAK). CAK is a multisubunit protein that includes CDK7 (MIM 601955), cyclin H (CCNH, MIM 601953), and MAT1. MAT1 (for 'menage a trois-1') is involved in the assembly of the CAK complex.[supplied by OMIM].
Alias Symbols: MAT1, TFB3, CAP35, RNF66
Protein Interaction Partner: MTA1,BRCA1,C1orf103,C7orf64,CDK7,COPS6,E2F1,EEF1A1,ERCC3,ESR1,GTF2E2,HPS6,MCM7,MTA1,POU2F1,POU2F2,POU5F1,RB1,TP53,C1orf103,C7orf64,CCNH,CDK7,COPS6,EEF1A1,ERCC3,ESR1,HPS6,MCM7,MTA1,POU2F1,POU2F2,POU5F1,RB1,TP53